Femasys shareholders approve reverse stock split (1:2 to 1:25) and anti-dilution share issuance

FEMASYS INC

Reverse split authorized by board at ratio of 1-for-2 to 1-for-25, with discretion until May 1, 2027; votes: 18.9M For, 5.2M Against.
Share issuance for anti-dilution provisions under Nov 2025 SPA and Mar 2026 amendment approved; votes: 7.5M For, 1.7M Against, 14.9M broker non-votes.
Both proposals passed; adjournment proposal not presented due to sufficient votes.
Special Meeting held April 29, 2026; ~39.91% of outstanding shares were represented.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.